Ophthalmic and Topical Dosage Form New Animal Drugs; Neomycin, Penicillin, Polymyxin, Hydrocortisone Topical Suspension

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect codification of a previously approved new animal drug application (NADA) held by Upjohn Co. The NADA provides for the safe use of Forte-Topical Suspension (neomycin, penicillin, polymyxin, hydrocortisone suspension) as a topical antibacterial and anti-inflammatory agent in dogs.